FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 143

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
FBRX Nasdaq Forte Biosciences, Inc. 2834
FLNA Nasdaq Filana Therapeutics, Inc. 2834
GLPG Nasdaq Galapagos NV 2834
GRI Nasdaq GRI Bio, Inc. 2834
HAWPY Over the counter Haw Par Corporation Limited 2834
HCM Nasdaq HUTCHMED (China) Limited 2834
HELP Nasdaq Cybin Inc. 2834
HKMPY Over the counter Hikma Pharmaceuticals PLC 2834
HLN New York Haleon plc 2834
HROW Nasdaq Harrow, Inc. 2834
IMA Nasdaq ImageneBio, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
INDP Nasdaq Indaptus Therapeutics, Inc. 2834
INDV Nasdaq Indivior Pharmaceuticals, Inc. 2834
INVA Nasdaq Innoviva, Inc. 2834
IOBT Nasdaq IO Biotech, Inc. 2834
IRON Nasdaq Disc Medicine, Inc. 2834
KALV Nasdaq KalVista Pharmaceuticals, Inc. 2834
KRYS Nasdaq Krystal Biotech, Inc. 2834
KTTA Nasdaq Pasithea Therapeutics Corp. 2834
LBRX Nasdaq LB Pharmaceuticals Inc 2834
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2834
MANE New York Veradermics, Incorporated 2834
MGX Nasdaq Metagenomi Therapeutics, Inc. 2834
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2834
MKKGY Over the counter Merck KGaA 2834
MLYS Nasdaq Mineralys Therapeutics, Inc. 2834
MTVA Nasdaq MetaVia Inc. 2834
MXCT Nasdaq MaxCyte, Inc. 2834
NBIX Nasdaq Neurocrine Biosciences, Inc. 2834
NGNE Nasdaq Neurogene Inc. 2834
NKTR Nasdaq Nektar Therapeutics 2834
NMRA Nasdaq Neumora Therapeutics, Inc. 2834
NNCHY Over the counter Nissan Chemical Corporation 2834
NSRX NYSE American Nasus Pharma Ltd. 2834
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2834
NVCT Nasdaq Nuvectis Pharma, Inc. 2834
OCGN Nasdaq Ocugen, Inc. 2834
OCS Nasdaq Oculis Holding AG 2834
OCUL Nasdaq Ocular Therapeutix, Inc. 2834
OMER Nasdaq Omeros Corporation 2834
ONC Nasdaq BeOne Medicines AG 2834
OPHLY Over the counter Ono Pharmaceutical Co., Ltd. 2834
ORIC Nasdaq ORIC Pharmaceuticals, Inc. 2834
ORINY Over the counter Orion Oyj 2834
OSTX NYSE American OS Therapies Incorporated 2834
OTLK Nasdaq Outlook Therapeutics, Inc. 2834
PALI Nasdaq Palisade Bio, Inc. 2834
PCSA Nasdaq Processa Pharmaceuticals, Inc. 2834
PHAT Nasdaq Phathom Pharmaceuticals, Inc. 2834
Results 50 through 100 of 143